Shares of Medtronic (NYSE:MDT) reached a session low on Tuesday after the U.S. Food and Drug Administration (FDA) announced a product recall involving the company’s Pipeline Vantage 027 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback